• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home StudyGraphics

#VisualAbstract: Long-term Outcomes Associated With Total Arterial Revascularization vs Non–Total Arterial Revascularization

byConstance Wu
April 10, 2020
in StudyGraphics
Reading Time: 2 mins read
#VisualAbstract: Long-term Outcomes Associated With Total Arterial Revascularization vs Non–Total Arterial Revascularization
Share on FacebookShare on Twitter

1. Total arterial vascularization (TAR) resulted in reduced likelihood of myocardial infarction, major cardio- and cerebrovascular events, and death compared to non-TAR in those requiring coronary artery bypass grafting.

Evidence Rating Level: 2 (Good)

Given the discussion surrounding multivessel coronary artery disease and the ideal conduits for coronary artery bypass grafting (CABG), there is a need to evaluate the long-term outcomes of total arterial revascularization (TAR) and non-TAR procedures, with non-TAR being CABG with at least one saphenous and one arterial vein graft. This multicenter, Canadian, population-based cohort study sought to investigate these clinical outcomes in primary isolated CABG with at least one arterial graft with a mean follow-up of 2.6 years (maximum follow-up 9.0 years). A total of 49,404 individuals with primary isolated CABG were identified (M [SD] age, 61.2 [10.4] years, 18.5% female), 4.9% of whom received TAR with total number of bypasses being 2 (62.5%), 3 (35.6%), or ≥4 (1.9%). Propensity score matching was used, resulting in 2,132 patient pairs with equivalent bypasses (mean [SD], 2.4 [0.5]) but a greater number of arterial grafts in the TAR group (mean difference 1.2, p<0.01). Deaths during hospitalization did not differ between the TAR (0.7%) and non-TAR groups (1.0%). Over the course of eight years, TAR was associated with attenuation of risk from major cerebro- and cardiovascular events (HR, 0.78, 95% CI 0.68 to 0.89), myocardial infarction (HR, 0.69, 95% CI 0.51 to 0.92), and death (HR, 0.80, 95% CI 0.66 to 0.97). Thus, this study suggests that TAR may be a wise clinical judgment among individuals who present with minimal risk factors and require CABG.

Click to read the study in JAMA Cardiology

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

Coronary CT-angiography-guided management improves outcomes in patients with stable chest pain

Social and genetic risk scoring may improve coronary heart disease risk prediction

Tags: Cardiac Catheterizationcoronary artery bypass surgery (CABG)coronary artery disease (CAD)multivessel disease
Previous Post

Critically ill COVID-19 patients may benefit from convalescent plasma therapy

Next Post

COVID-19 patients with coagulation dysfunction may benefit from prophylactic anticoagulation

RelatedReports

Lariat device for left atrial appendage exclusion associated with adverse events
Cardiology

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

January 13, 2026
Physician visual assessment of coronary stenosis severity overestimates quantitative coronary angiography
Cardiology

Coronary CT-angiography-guided management improves outcomes in patients with stable chest pain

August 29, 2026
Cardiology

Social and genetic risk scoring may improve coronary heart disease risk prediction

December 9, 2024
#VisualAbstract Edoxaban Monotherapy has Lower Risks for Atrial Fibrillation and Stable Coronary Artery Disease than Dual Antithrombotics
StudyGraphics

#VisualAbstract Edoxaban Monotherapy has Lower Risks for Atrial Fibrillation and Stable Coronary Artery Disease than Dual Antithrombotics

September 10, 2024
Next Post
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

COVID-19 patients with coagulation dysfunction may benefit from prophylactic anticoagulation

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Landiolol effective at controlling heart rate in sepsis related tachyarrhythmias

Initial data on the viability of SARS-CoV-2 in aerosol and on surfaces

Clinical and epidemiologic features of COVID-19 in children

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.